Sign in

What researchers published on Triple-negative breast cancer

19,695 papers, newest first.

Showing 100 of 19,695

  • RGDfC-functionalized gold nanoclusters versus the clinical radiosensitizer sodium glycididazole in triple-negative breast cancer radiotherapy.PloS one
  • Phase-Space Distance Between Stationary States Modulates Phenotypic Plasticity in Breast Cancer.Bulletin of mathematical biology
  • Tumor-targeted transferrin nanoassemblies delivering olaparib and curcumin for combating BCRP-mediated resistance in triple-negative breast cancer.Biomaterials science
  • Case reportPembrolizumab-Associated Secondary Adrenal Insufficiency Due to Isolated Adrenocorticotropic Hormone (ACTH) Deficiency Presenting as Recurrent Multisystem Decompensation in Triple-Negative Breast Cancer.Cureus
  • Tertiary lymphoid structures and the systemic immune-inflammation index define distinct pathologic response phenotypes in triple-negative breast cancer receiving neoadjuvant chemoimmunotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • MRI Radiomics-Based Nomogram Integrating Skeletal Muscle Assessment for Predicting Pathologic Complete Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Diagnostics (Basel, Switzerland)
  • β-galactosidase-activatable photosensitization for selective, light-amplified pyroptosis therapy of triple-negative breast Cancer cells.Bioorganic chemistry
  • In Vitro Models of Triple-Negative Breast Cancer of Sub-Saharan African Ancestry Suggest BLM-Centred DNA Damage Repair Dependency and Pevonedistat Sensitivity.International journal of molecular sciences
  • ReviewThe Role of Hypoxia-Inducible Factors (HIFs) in Triple-Negative Breast Cancer Radiation Resistance.International journal of molecular sciences
  • Leptin-Driven Distinct Transcriptional Reprogramming in Triple-Negative Breast Cancer: Implications for Racial Disparities.International journal of molecular sciences
  • Meta-analysisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
  • Promoter hypomethylation associated with elevated TRIM33 expression in triple-negative breast cancer patients.Frontiers in oncology
  • Early Change in the Pan-Immune-Inflammation Value During Neoadjuvant Chemotherapy Is Associated with Pathological Complete Response in HER2-Positive and Triple-Negative Breast Cancer: A Single-Centre Study with Temporal Validation.Journal of clinical medicine
  • ReviewRecent Advances in Mitochondria-Targeted Nanoparticle Photodynamic Therapy for Triple-Negative Breast Cancer.International journal of molecular sciences
  • RETRACTED: Kim et al. Autocrine Motility Factor and Its Peptide Derivative Inhibit Triple-Negative Breast Cancer by Regulating Wound Repair, Survival, and Drug Efflux. Int. J. Mol. Sci. 2024, 25, 11714.International journal of molecular sciences
  • Updated results from ASCENT-J02, a study of sacituzumab govitecan in Japanese participants with metastatic triple-negative breast cancer.International journal of clinical oncology
  • ReviewSQSTM1/p62 and Mitochondrial Stress in Triple-Negative Breast Cancer: A Critical Pathology Perspective.Cancers
  • Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib.Tissue & cell
  • Matrix-Associated Gene Expression and Annotated Tumor-Stroma Composition of Transcriptomically Defined Cold Regions in Triple-Negative Breast Cancer.Cancers
  • Oral 25-Hydroxycholesterol Suppresses 4T1 Tumour Growth in an Immune-Context-Associated Manner.International journal of molecular sciences
  • Neoadjuvant Versus Adjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer: A National Cancer Database Study.Cancers
  • ReviewCirculating Non-Coding RNAs as Liquid Biopsy Biomarkers for Early Detection of Triple-Negative Breast Cancer: From Diagnostic Performance to Clinical Translation.Diagnostics (Basel, Switzerland)
  • Cell-Cell Communication Network Analysis of Tertiary Lymphoid Structures in Triple-Negative Breast Cancer.Current cancer drug targets
  • CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell-suppressive function in triple-negative breast cancer and other immunoregulatory settings.Journal of immunology (Baltimore, Md. : 1950)
  • Dual-Targeted Nanoparticle Chimeras Induce Bioenergetic Crisis by Coupling Lipid Droplet Degradation with Nicotinamide Adenine Dinucleotide Reduction in Triple-Negative Breast Cancer.Acta biomaterialia
  • Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor.Pharmacological research
  • FOXA1 expression and survival outcomes in triple-negative breast cancer: A retrospective cohort study.PloS one
  • Beyond resveratrol: Vitis vinifera grape cane extracts selectively induce apoptosis in glioblastoma and triple-negative breast cancer cells via Bcl-2/Bax/Caspase-3 pathway.Fitoterapia
  • HOXC12 Expression in Triple-negative Breast Cancer: Clinicopathological Correlations and Potential as a Prognostic Biomarker.Current drug targets
  • ReviewThe HLA-E-NKG2A axis in breast cancer: an emerging NK-cell checkpoint and therapeutic target.Frontiers in immunology
  • Patient-reported outcomes from ASCENT-03: sacituzumab govitecan vs chemotherapy in advanced triple-negative breast cancer.The oncologist
  • Correction: Eustace et al. TP53 Mutation-Specific Dysregulation of Store-Operated Calcium Entry and Apoptotic Sensitivity in Triple-Negative Breast Cancer. Cancers 2025, 17, 1614.Cancers
  • Effectiveness and Toxicity Burden of Pembrolizumab in Combination With Neoadjuvant Chemotherapy for Stage II/III Triple Negative Breast Cancer: A Real-World Analysis From Alberta, Canada.American journal of clinical oncology
  • Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program.Breast (Edinburgh, Scotland)
  • SIMMPYRA1 and SIMMPYRA2 suppress triple-negative breast cancer growth through selective STAT3 inhibition.Cell chemical biology
  • Relevance of toll-like receptor-4 in the pathogenesis of triple negative breast cancer.Molecular biology reports
  • CDK4/6-Mediated Growth Arrest Enhances Cell Stiffness and Contractility in RB-Proficient Triple-Negative Breast Cancer Cells in 3D Hydrogels.Tissue engineering. Part A
  • RBP1-driven retinol metabolism in tumor-associated lymphatic endothelial cells orchestrates triple-negative breast cancer progression and lymphatic metastasis.Experimental hematology & oncology
  • Treatment-associated remodeling of a mitochondrial translation-related gene set in paired pretreatment and residual triple-negative breast tumors.Neoplasia (New York, N.Y.)
  • Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cells.Frontiers in cell and developmental biology
  • Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan.Breast cancer (Tokyo, Japan)
  • ReviewGlutamine as a context-dependent regulator controlling metabolism and immunity in triple-negative breast cancer.Cell communication and signaling : CCS
  • Meta-analysisReal-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis.BMC cancer
  • Analyzing per- and polyfluoroalkyl substances (PFAS) in triple-negative breast cancer (TNBC): an integrative transcriptomic and computational study.Cell biology and toxicology
  • Antibody-drug conjugates therapy for triple-negative breast cancer: a systematic review and meta-analysis.Frontiers in medicine
  • CD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
  • Bifunctional EGFR/CD44-Targeted Diabody-Decorated Doxorubicin-Loaded Solid Lipid Nanoparticles for Targeted Therapy in Triple-Negative Breast Cancer.Advanced pharmaceutical bulletin
  • Egonol restores tamoxifen sensitivity via the miR-3529-5p-CLOCK axis in triple-negative breast cancer cells.Fitoterapia
  • Effect of Exosome-loaded hsa-miR-203a-3p on Triple Negative Breast Cancer Cell Viability, Migration, and Gene Targets: In Silico and In Vitro Study.Advanced pharmaceutical bulletin
  • CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer.Journal of inflammation research
  • CircEML1 upregulates BTG2 to suppress the progression of triple-negative breast cancer.Biology direct
  • Biotin-Functionalized Multi-Stimuli-Responsive Polymeric Prodrug for Receptor-Mediated and Mitochondria-Targeted Codelivery of Camptothecin and Protocatechualdehyde.Biomacromolecules
  • Targeting CD44v3 rescues Entrectinib response in brain metastasis of triple negative breast cancer overexpressing TrkA.Signal transduction and targeted therapy
  • Decoding neutrophil spatial heterogeneity and clinical implications in breast cancer.Cancer cell
  • Geographical access to radiotherapy and surgical treatment selection in older women with HER2-positive and triple-negative breast cancer: A real-world exploratory study.Journal of geriatric oncology
  • Durable Treatment-Free Remission in BRCA1-Associated Metastatic Triple-Negative Breast Cancer with Brain and Radiologically Diagnosed Hepatic Metastases: A Case Report.Oncology and therapy
  • ReviewBrain Metastasis of Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.The breast journal
  • Subtype conversion and metastatic timing in breast cancer liver metastasis.World journal of surgical oncology
  • Neutrophils are known by their neighbors in breast cancer.Cancer cell
  • Hyaluronic acid-engineered NLCs as a macromolecular delivery platform for APOBEC3B siRNA and gemcitabine in triple-negative breast cancer: In vitro to in ovo assay.International journal of biological macromolecules
  • Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).BMC medicine
  • PreprintSpatial context of cellular heterogeneity in triple-negative breast cancer reveals actionable subtypes.bioRxiv : the preprint server for biology
  • PreprintReprogramming CAR-T cell function through synthetic cytokine receptors suppresses metastatic progression of TNBC.bioRxiv : the preprint server for biology
  • IMPACT: Investigating Metaplastic Breast Cancer Prognosis against Conventional Triple-Negative Invasive Ductal Carcinoma.Indian journal of surgical oncology
  • PreprintTamoxifen and Doxorubicin Synergistically Target Estrogen Receptor β-Mutant p53-p73 Axis, a Therapeutically Actionable Vulnerability in Triple Negative Breast Cancer.bioRxiv : the preprint server for biology
  • Therapeutic value of PD-1/PD-L1 blockade plus chemotherapy in advanced or metastatic triple-negative breast cancer: a systematic review and meta-analysis of randomized controlled trials.Translational cancer research
  • Case reportCase Report: Unicentric Castleman disease mimicking metastatic lymphadenopathy in a patient with a history of triple-negative breast cancer and angiomatoid fibrous histiocytoma.Frontiers in oncology
  • Uncovering the immune microenvironmental atlas of breast cancer molecular subtypes based on single-cell transcriptomics.PloS one
  • ReviewAdvanced platinum strategies for triple-negative breast cancer.Trends in pharmacological sciences
  • Sacituzumab govitecan plus toripalimab compared with toripalimab plus nab-paclitaxel for first-line treatment of unresectable, locally advanced, or metastatic triple-negative breast cancer: protocol of a multicenter, open-label, randomized phase II trial.Translational breast cancer research : a journal focusing on translational research in breast cancer
  • PreprintAndrogen receptor expression is associated with a distinct low-proliferative phenotype in triple-negative breast cancer.Research square
  • Benefits and adverse events of combined chemotherapy and immune checkpoint inhibition in non-metastatic triple-negative breast cancer: a systematic review and an updated meta-analysis.Translational breast cancer research : a journal focusing on translational research in breast cancer
  • TRPA1 blockade potentiates a ferroptosis-driven in situ vaccine nanoplatform for enhanced ROS immunotherapy against TNBC.Materials today. Bio
  • Preclinical Evaluation of cRGD-Functionalized Lipid-Polymer Hybrid Nanocarriers for Anti-VEGF Gene Therapy in Triple-Negative Breast Cancer.Drug development research
  • Claudin-1 re-expression as a therapeutic strategy in Triple-negative breast cancer: transcriptional regulation.Molecular biology reports
  • O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability.Biochimica et biophysica acta. Molecular basis of disease
  • Real-World Toxicity and Outcomes of KEYNOTE-522-Style Neoadjuvant Pembrolizumab for Triple-Negative Breast Cancer in Australia.Asia-Pacific journal of clinical oncology
  • PreprintResponse to SMAC mimetics in patient-derived models of triple-negative breast cancer relies on RIPK1 activation.bioRxiv : the preprint server for biology
  • LARP1-mediated stabilization of CD73 mRNA promotes immune escape in triple-negative breast cancer.Frontiers in immunology
  • Identification of SLC7A5 and transferrin as key ferroptosis modulators in triple-negative breast cancer.Oncology letters
  • Evaluating Physician Perspectives on Neoadjuvant Immunotherapy and Chemotherapy for Early-Stage Triple-Negative Breast Cancer.Clinical breast cancer
  • Impact of Neoadjuvant Carboplatin in Early-Stage Triple-Negative Breast Cancer: A Pooled Analysis of the BrighTNess, Cancer and Leukemia Group B 40603 (Alliance), and GeparSixto Clinical Trials.JCO oncology advances
  • Case reportCase Report: Prolonged survival following multimodal treatment of leptomeningeal metastases in triple-negative glycogen-rich clear cell breast carcinoma.Frontiers in oncology
  • Targeting the ERO1A-PDIA1 redox axis in triple-negative breast cancer with AI-designed minibinders.Cell death discovery
  • Quercetin Promotes Apoptosis of Triple-Negative Breast Cancer Cells by Inducing Endoplasmic Reticulum Stress and Activating the ATF4/CHOP Pathway.Anti-cancer agents in medicinal chemistry
  • Biochanin A Induces Cuproptosis and Inhibits Lung Metastasis in triple-negative Breast Cancer.Oncology research
  • RHBDL2 promotes cancer stemness and chemoresistance in triple-negative breast cancer through EGFR/PI3K/AKT/mTOR/c-Myc pathway.Oncogene
  • TFAP2A promotes the stemness and metastasis of luminal B/HER2-positive and triple-negative breast cancer cells by enhancing KDM4B transcriptional activity.Molecular biology reports
  • Pluronic F-127-functionalized magnetic ternary hybrid nanoparticles for co-delivery of paclitaxel and psoralen: a synergistic strategy to overcome multidrug resistance in triple-negative breast cancer.Frontiers in pharmacology
  • SAGE1-Mediated H3K27ac Enrichment Promotes Chromatin Opening and Fanconi Anemia Repair to Induce Carboplatin Resistance in Triple-Negative Breast Cancer.Cancer letters
  • One size does not fit all: the inclusion of carboplatin in neoadjuvant treatment of triple-negative breast cancer.Chinese clinical oncology
  • Activity and safety of first-line pumitamig plus nab-paclitaxel in triple-negative breast cancer: a single-arm, phase 1b/2 trial.The Lancet. Oncology
  • STEAP3 Modulates Macrophage Polarization in TNBC by Promoting Nuclear Transport of ERK5.The Tohoku journal of experimental medicine
  • Novel aptamer-based strategies for addressing aggressive and heterogeneous triple-negative breast cancer.Frontiers in oncology
  • Trial resultEribulin mesylate in combination with ivonescimab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer(EMIT): study protocol for a single-arm, multicenter clinical trial.Frontiers in immunology
  • Trophoblast cell-surface antigen 2-directed enhancement of gene delivery using a nanobody-engineered recombinant adeno-associated virus for bispecific T-cell engager-mediated T-cell cytotoxicity in triple-negative breast cancer cells.International journal of biological macromolecules
  • Predicting neoadjuvant chemotherapy efficacy in triple-negative breast cancer using DCE-MRI and mammographic texture.Breast cancer (Tokyo, Japan)
  • Integrating AI-Based De Novo Design with Molecular Docking and Density Functional Theory Analysis to Optimize Flavonoid Scaffolds as p53-MDM2 Inhibitors for Triple-Negative Breast Cancer.Current topics in medicinal chemistry
  • Dual-organelle-coordinated sonodynamic nanoplatform amplifies immunogenic cell death to drive robust antitumor immunity in cold tumors.Journal of nanobiotechnology
  • ReviewResearch progress on the key cuproptosis regulator FDX1 and its relevance to triple-negative breast cancer.Frontiers in molecular biosciences